HEALTH, SUBJECTIVE
Clinical trials for HEALTH, SUBJECTIVE explained in plain language.
Never miss a new study
Get alerted when new HEALTH, SUBJECTIVE trials appear
Sign up with your email to follow new studies for HEALTH, SUBJECTIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Mindfulness program aims to ease stress for head start teachers
Symptom relief CompletedThis study tested an 8-week mindfulness program called CHIME for Early Head Start and Head Start educators. The goal was to see if it improves their emotional well-being, reduces stress, and boosts self-compassion. Researchers also looked at whether the program helps children's s…
Matched conditions: HEALTH, SUBJECTIVE
Phase: NA • Sponsor: University of Nebraska Lincoln • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
Essential oil pills: do capsules change how they work?
Knowledge-focused CompletedThis study looked at how healthy adults absorb frankincense, lemon, and wild orange essential oils when taken in different types of capsules. Nineteen people took part, and researchers measured oil levels in the blood over 24 hours. The goal was to see if the capsule type changes…
Matched conditions: HEALTH, SUBJECTIVE
Phase: NA • Sponsor: University of Mississippi Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
New tool aims to measure health in down syndrome for the first time
Knowledge-focused CompletedThis study created a new questionnaire called the Down Syndrome Health Instrument (DHI) to measure health in people with Down syndrome. Researchers worked with caregivers, individuals with Down syndrome, and experts to develop and test the tool. Over 750 participants took part in…
Matched conditions: HEALTH, SUBJECTIVE
Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:25 UTC
-
Healthy volunteers help test new Drug's safety
Knowledge-focused CompletedThis early-stage study tested the safety and tolerability of a drug called ALT-BB4 in 290 healthy adults. Researchers monitored for allergic reactions and other side effects. The goal was to gather safety information, not to treat any disease.
Matched conditions: HEALTH, SUBJECTIVE
Phase: PHASE1 • Sponsor: Alteogen, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC